Current research indicates that Cystatin C, tissue inhibitor of metalloproteinases 2 (Timp-2) and insulin-like growth factor binding protein 7 (IGFBP7) are valuable markers for the diagnosis of AKI, but more studies are needed for HCE patients (21). Here, IGFBP7 is linked to acute kidney injury.